WRBY
Warby Parker Inc
NYSE: WRBY · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$22.53
-3.10% today
Updated 2026-04-28
Market cap
$2.63B
P/E ratio
2,147.00
P/S ratio
3.02x
EPS (TTM)
$0.01
Dividend yield
—
52W range
$15 – $31
Volume
2.8M
Warby Parker Inc (WRBY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $370.46M | $393.72M | $540.80M | $598.11M | $669.76M | $771.32M | $871.90M |
| Revenue growth (YoY) | — | +6.3% | +37.4% | +10.6% | +12.0% | +15.2% | +13.0% |
| Cost of revenue | $147.35M | $161.78M | $223.05M | $257.05M | $304.54M | $344.48M | $401.33M |
| Gross profit | $223.11M | $231.94M | $317.75M | $341.06M | $365.22M | $426.83M | $470.58M |
| Gross margin | 60.2% | 58.9% | 58.8% | 57.0% | 54.5% | 55.3% | 54.0% |
| R&D | — | — | — | — | — | — | — |
| SG&A | $181.47M | $229.07M | $374.41M | $375.37M | $345.47M | $344.25M | $475.92M |
| Operating income | $-1.66M | $-55.63M | $-143.66M | $-111.20M | $-72.00M | $-30.11M | $-5.34M |
| Operating margin | -0.4% | -14.1% | -26.6% | -18.6% | -10.7% | -3.9% | -0.6% |
| EBITDA | $12.85M | $-37.26M | $-121.70M | $-78.03M | $-33.44M | $15.75M | $53.32M |
| EBITDA margin | 3.5% | -9.5% | -22.5% | -13.0% | -5.0% | 2.0% | 6.1% |
| EBIT | $-1.66M | $-55.63M | $-143.66M | $-109.90M | $-72.00M | $-30.11M | $3.04M |
| Interest expense | $1.94M | $97000.00 | $347000.00 | $1.31M | — | — | — |
| Income tax | $276000.00 | $190000.00 | $263000.00 | $497000.00 | $433000.00 | $875000.00 | — |
| Effective tax rate | -0.5% | -0.3% | -0.2% | -0.5% | -0.7% | -4.5% | 0.0% |
| Net income | $-57.54M | $-55.92M | $-144.27M | $-110.39M | $-63.20M | $-20.39M | $1.64M |
| Net income growth (YoY) | — | +2.8% | -158.0% | +23.5% | +42.8% | +67.7% | +108.0% |
| Profit margin | -15.5% | -14.2% | -26.7% | -18.5% | -9.4% | -2.6% | 0.2% |